{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:30:25Z","timestamp":1767929425966,"version":"3.49.0"},"reference-count":37,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\nBackground The purpose of the present study was to determine whether patients with DM1 have shown improvement, stabilization or deterioration of their urine albumin excretion levels during a close follow-up.<\/jats:p><jats:p>\nPatients and Methods A cohort of 84 patients, 18\u201376 years of age, a median duration of diabetes of 24 years (1\u201350 years) and a median follow-up duration of 12 years (1\u201337 years) were included in the study.<\/jats:p><jats:p>\nResults Among the 84 patients for whom we had UAE levels at the beginning and by the end of the study, mean glycosylated hemoglobin was statistically significantly decreased during the follow-up period, from 8.02\u00b12.04\u20137.06\u00b11.05% (p=0.036). Normoalbuminuria was present in 66 patients and remained so in 56 patients while 9 patients progressed to microalbuminuria and one patient to macroalbuminuria by the end of the study. Microalbuminuria was present in 15 patients: regression was observed in 8 patients, and progression in one patient. Regression of macroalbuminuria to microalbuminuria was noted in one patient and to normoalbuminuria was noted in one participant, too.<\/jats:p><jats:p>\nConclusions Improvement of glycemic control with close monitoring of DM1 patients together with the appropriate use ACE or AT2 inhibitors and statins, seems to exert nephron-protective potential and to delay or even reverse the presence of micro\/macroalbuminuria. This long term follow-up study has demonstrated a statistically significant increase in serum HDLcholesterol levels. The study also revealed that intensively treated diabetes patients may show reductions in serum ALP levels. Whether this finding is related to diabetic nephropathy, NAFLD, or diabetic hepatosclerosis remains to be assessed in future trials.<\/jats:p>","DOI":"10.1055\/a-0848-8076","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T23:46:51Z","timestamp":1551138411000},"page":"276-282","source":"Crossref","is-referenced-by-count":1,"title":["Progression of Albuminuria Among Patients with Type 1 Diabetes Mellitus: A Long Term Observational Follow-up Study"],"prefix":"10.1055","volume":"129","author":[{"given":"Theodora","family":"Stratigou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Vallianou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Koutroumpi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Vlassopoulou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theofanis","family":"Apostolou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stylianos","family":"Tsagarakis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ioannidis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.1989.03420080075034","article-title":"Glucose control and the renal and retinal complications of insulin-dependent diabetes","volume":"261","author":"H P Chase","year":"1989","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00284458","article-title":"Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study","volume":"25","author":"A R Andersen","year":"1983","journal-title":"Diabetologia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9343(85)90284-0","article-title":"The changing natural history of nephropathy in type I diabetes","volume":"78","author":"A S Krolewski","year":"1985","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db08-1543","article-title":"FinnDiane Study Group. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"P H Groop","year":"2009","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","article-title":"In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"53","author":"T J Orchard","year":"2010","journal-title":"Diabetologia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","article-title":"For the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria. an analysis of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort","volume":"171","author":"Boer de","year":"2011","journal-title":"Arch Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"L A Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000096407","article-title":"The New KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and CKD screening and diagnosis of diabetic kidney disease","volume":"25","author":"R G Nelson","year":"2007","journal-title":"Blood Purif"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"Collaborative study. The effect of angiotensin converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"E J Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ki.2011.413","article-title":"The impact of renin-angiotensin-aldosterone system inhibitors on type 1 and type 2 diabetic patients with and without early diabetic nephropathy","volume":"81","author":"J A Hirst","year":"2012","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2010.58","article-title":"The RAAS in the pathogenesiis and treatment of diabetic nephropathy","volume":"6","author":"P Ruggenenti","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2010040354","article-title":"Risk of ESRD in type 1 diabetes remains high in spite of renoprotection","volume":"22","author":"E T Rosolowsky","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2010020194","article-title":"FinnDiane Study Group. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria","volume":"22","author":"C Forsblom","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","article-title":"Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group","volume":"272","author":"G Viberti","year":"1994","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0002-9343(99)80226-5","article-title":"The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group","volume":"99","author":"L M Laffel","year":"1995","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/dc13-2113","article-title":"Kidney disease and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"I H de Boer","year":"2014","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependentdiabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1523-1755.2001.00789.x","article-title":"EURODIAB prospective complications study group: Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold","volume":"60","author":"N Chaturvedi","year":"2001","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3810\/pgm.2011.11.2501","article-title":"Intensive glycemic control and cardiovascular disease; Are there patients who may benefit?","volume":"123","author":"N Chokrungvaranon","year":"2011","journal-title":"Postgrad Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2337\/dc06-0239","article-title":"Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes. A longitudinal study","volume":"29","author":"M L Stone","year":"2006","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa021835","article-title":"Regression of microalbuminuria in type 1 diabetes","volume":"348","author":"B A Perkins","year":"2003","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2006080872","article-title":"Microalbuminuria and risk of early progressive renal function decline in type 1 diabetes","volume":"18","author":"B A Perkins","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/dc15-0184","article-title":"Progressive Renal Decline: The new paradigm of diabetic nephropathy in type 1 diabetes","volume":"38","author":"A S Krolewski","year":"2015","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/dc08-1641","article-title":"Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes","volume":"32","author":"M L Marcovecchio","year":"2009","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jpeds.2005.04.068","article-title":"Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus","volume":"147","author":"D M Maahs","year":"2005","journal-title":"J Pediatr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/diacare.29.02.06.dc05-0724","article-title":"DPV Initiative of the German Working Group for Pediatric Diabetology. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)","volume":"29","author":"K O Schwab","year":"2006","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpeds.2006.10.054","article-title":"Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes","volume":"150","author":"D M Maahs","year":"2007","journal-title":"J Pediatr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpeds.2006.04.065","article-title":"Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study","volume":"149","author":"A K Kershnar","year":"2006","journal-title":"J Pediatr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/diacare.8.2.118","article-title":"The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus","volume":"8","author":"K J Cruickshanks","year":"1985","journal-title":"Diabetes Care"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/diab.32.1.20","article-title":"Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients: A longitudinal study","volume":"32","author":"M F Lopes-Virella","year":"1983","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-9136(199703)14:3<242::AID-DIA340>3.0.CO;2-1","article-title":"Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus","volume":"14","author":"N Attia","year":"1997","journal-title":"Diabet Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/0886022X.2013.872569","article-title":"Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients","volume":"36","author":"T Bulum","year":"2014","journal-title":"Ren Fail"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/clinchem\/43.8.1357","article-title":"Increased alkaline phosphatase isoforms in autoimmune diseases","volume":"43","author":"A N Hanna","year":"1997","journal-title":"Clin Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1478-3231.2008.01956.x","article-title":"Diabetic hepatosclerosis: A 10-year autopsy series","volume":"29","author":"G Chen","year":"2009","journal-title":"Liver Int"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/dme.12898","article-title":"Diabetic hepatosclerosis: Another diabetes microvascular complication?","volume":"33","author":"R J King","year":"2016","journal-title":"Diabet Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0000000000000419","article-title":"Hepatic arteriolosclerosis: A small-vessel complication of diabetes and hypertension","volume":"39","author":"M Balakrishnan","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Experimental and Clinical Endocrinology &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-0848-8076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:24:49Z","timestamp":1617063889000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-0848-8076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":37,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,3,29]]},"published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-0848-8076","relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]}}}